概括
预测人类免疫缺陷病毒 (HIV) 的耐药性至关重要. 一个新的模型预测了病毒的进化,并确定了关键突变,表明阿塔萨纳维尔 (ATV) 和里托纳维尔 (RTV) 组合疗法是最不耐药的.
科学领域:
- 计算生物学是一种计算生物学.
- 病毒学 病毒学
- 药物耐药性研究的研究.
背景情况:
- 蛋白酶抑制剂 (PI) 对人类免疫缺陷病毒 (HIV) 治疗至关重要.
- 药物耐药菌株出现,危及PI的疗效.
- 预测耐药性对于有效的治疗策略至关重要.
研究的目的:
- 开发一种概率模型来推断表观相互作用和预测病毒演变.
- 为了确定驱动耐药性的关键突变.
- 为了评估不同PI组合疗法的耐药性.
主要方法:
- 开发了一个概率的大偏差模型来推断表观相互作用.
- 模拟的随机进化路径,按突变过渡概率加权.
- 训练有素的分类模型在体外敏感性数据上推断药物耐药性.
- 沿着模拟的进化路径预测的耐药性.
主要成果:
- 低概率突变对于病毒群体来说是必要的,以演变多样化,适合基因型.
- ATAZANAVIR (ATV) 和RITONAVIR (RTV) 的联合治疗显示出最少的耐药性.
- 该模型预测了已知的初级和二级PI耐药突变,而没有先前的知识.
结论:
- 开发的模型有效地从稀疏的序列数据中推断出机械关系.
- 该模型可以预测耐药性,并识别病毒进化中的关键突变.
- 预计ATV/RTV组合疗法对抗药物耐药性最有效.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...


